ADVFN Logo ADVFN

We could not find any results for:
Make sure your spelling is correct or try broadening your search.

Trending Now

Toplists

It looks like you aren't logged in.
Click the button below to log in and view your recent history.

Sign Up

Already a member? Sign in

Options Flow

Live Options Flow

Market Data
News
Trading Tools
Markets
Discover

Hot Features

Follow Feed

Connect with traders and investors in our Follow Feed community.

Options Flow

Explore comprehensive options data and use advanced filters with Options Flow.

Monitor

Organize and monitor your stock and asset watchlist with Monitor.
Sign In Premium IconPremium Help Menu
S&P TSX Capped Composite...
34.60
-0.14%
US Tech 100
19,409.60
1.26%
S&P 500
5,473.23
0.77%
US Dollar vs CAD
1.37383
0.18%
Bitcoin
65,426.37
-1.59%
Registration Strip Icon for pro Trade like a pro: Leverage real-time discussions and market-moving ideas to outperform.
Get Started
  1. Home
  2. Investing
  3. Stocks
  4. USA
  5. USOTC
  6. Oncology Pharma Inc (CE) (ONPH)

  7. Oncology Pharma Inc (CE) (ONPH) News

ONPH

Oncology Pharma (CE) (ONPH)

Oncology Pharma Inc (CE)
Date:
Sort by:
 Showing the most relevant articles for your search:USOTC:ONPH
DateTimeSourceHeadlineSymbolCompany
07/12/20227:36AMInvestorsHub NewsWireOncology Pharma Conducting Interviews and Presentations with Investors to Pursue Next Steps to Forward The Development Process of Nanoemulsion Drug Delivery SystemUSOTC:ONPHOncology Pharma Inc (CE)
06/29/20228:23AMInvestorsHub NewsWireOncology Pharma Conducting All The Preparations to Take Steps to Forward The Development Process of Nanoemulsion Drug Delivery SystemUSOTC:ONPHOncology Pharma Inc (CE)
06/08/20227:17AMInvestorsHub NewsWireOncology Pharma Announces: Initial Feasibility Study of the Nanoemulsion Drug Delivery System is Complete and Results Have Met the Threshold for Moving Forward To the Next Steps of DevelopmentUSOTC:ONPHOncology Pharma Inc (CE)
05/09/20227:48AMInvestorsHub NewsWireOncology Pharma Advances Progress on Multiple Fronts Including Advanced Attention to Connect2Trials' Commercial DevelopmentUSOTC:ONPHOncology Pharma Inc (CE)
04/13/20227:45AMInvestorsHub NewsWireOncology Pharma Completes Feasibility Phase of its Licensed Nanoemulsion Drug Delivery System to Treat CancerUSOTC:ONPHOncology Pharma Inc (CE)
03/02/20227:03AMInvestorsHub NewsWireOncology Pharma Reports on Progress with Ribera SolutionsUSOTC:ONPHOncology Pharma Inc (CE)
02/23/20227:00AMInvestorsHub NewsWireOncology Pharma Releases Further Feasibility Studies, Data and CapacitiesUSOTC:ONPHOncology Pharma Inc (CE)
02/17/20227:16AMInvestorsHub NewsWireOncology Pharma Expands on Feasibility Studies and DataUSOTC:ONPHOncology Pharma Inc (CE)
02/14/20227:11AMInvestorsHub NewsWireOncology Pharma, Inc. and Regen BioPharma, Inc. Announce Intent to Jointly Fast Track Development of Modified mRNA anti-Cancer VaccineUSOTC:ONPHOncology Pharma Inc (CE)
02/08/20227:30AMInvestorsHub NewsWireOncology Pharma Gives Update on Technology, Formulation and Data CreationUSOTC:ONPHOncology Pharma Inc (CE)
01/10/20227:15AMInvestorsHub NewsWireOncology Pharma's New Year UpdateUSOTC:ONPHOncology Pharma Inc (CE)
12/17/20217:11AMInvestorsHub NewsWireOncology Pharma Meeting Towards Future DevelopmentsUSOTC:ONPHOncology Pharma Inc (CE)
12/09/20217:04AMInvestorsHub NewsWireOncology Pharma Year End Review and OutlookUSOTC:ONPHOncology Pharma Inc (CE)
11/30/20217:02AMInvestorsHub NewsWireOncology Pharma Research and VisionUSOTC:ONPHOncology Pharma Inc (CE)
11/08/20217:00AMInvestorsHub NewsWireOncology Pharma Reveals Plans for Development of Lead Cancer Drug CandidateUSOTC:ONPHOncology Pharma Inc (CE)
10/28/202110:11AMInvestorsHub NewsWireOncology Pharma, Inc. Gives Update on Ongoing Work and ProgressUSOTC:ONPHOncology Pharma Inc (CE)
10/15/20217:12PMStockInvest.usHigh volatility in Oncology Pharma Inc. stock price on Friday which ended trading at $13.95USOTC:ONPHOncology Pharma Inc (CE)
10/15/20217:12PMStockInvest.usHigh volatility in Oncology Pharma Inc. stock price on Friday which ended trading at $13.95USOTC:ONPHOncology Pharma Inc (CE)
10/15/20217:12PMStockInvest.usHigh volatility in Oncology Pharma Inc. stock price on Friday which ended trading at $13.95USOTC:ONPHOncology Pharma Inc (CE)
10/15/20217:12PMStockInvest.usHigh volatility in Oncology Pharma Inc. stock price on Friday which ended trading at $13.95USOTC:ONPHOncology Pharma Inc (CE)
10/15/20219:51AMInvestorsHub NewsWireOncology Pharma, Inc. Has Engaged a PCAOB Audit Firm Looking Towards Moving the Company Towards a Senior ListingUSOTC:ONPHOncology Pharma Inc (CE)
10/12/20217:30AMInvestorsHub NewsWireOncology Pharma, Inc. Update on PCAOB Audit Selection Process and License AgreementUSOTC:ONPHOncology Pharma Inc (CE)
10/04/20217:09PMStockInvest.usBig movements in Oncology Pharma Inc. stock price on Monday moving 40.14% between high and lowUSOTC:ONPHOncology Pharma Inc (CE)
10/04/20217:09PMStockInvest.usBig movements in Oncology Pharma Inc. stock price on Monday moving 40.14% between high and lowUSOTC:ONPHOncology Pharma Inc (CE)
10/04/20217:09PMStockInvest.usBig movements in Oncology Pharma Inc. stock price on Monday moving 40.14% between high and lowUSOTC:ONPHOncology Pharma Inc (CE)
10/04/20217:09PMStockInvest.usBig movements in Oncology Pharma Inc. stock price on Monday moving 40.14% between high and lowUSOTC:ONPHOncology Pharma Inc (CE)
10/04/20217:09PMStockInvest.usBig movements in Oncology Pharma Inc. stock price on Monday moving 40.14% between high and lowUSOTC:ONPHOncology Pharma Inc (CE)
10/04/20217:09PMStockInvest.usBig movements in Oncology Pharma Inc. stock price on Monday moving 40.14% between high and lowUSOTC:ONPHOncology Pharma Inc (CE)
10/04/20217:09PMStockInvest.usBig movements in Oncology Pharma Inc. stock price on Monday moving 40.14% between high and lowUSOTC:ONPHOncology Pharma Inc (CE)
09/16/20217:08PMStockInvest.usHigh volatility in Oncology Pharma Inc. stock price on Thursday which ended trading at $11.35USOTC:ONPHOncology Pharma Inc (CE)
 Showing the most relevant articles for your search:USOTC:ONPH

Your Recent History

USOTC
VXIT
Virexit Technologies (PK)
USOTC
ILST
International Star (PK)
USOTC
TKMO
Tekumo (PK)
USOTC
RSPI
RespireRx Pharmaceuticals (PK)
USOTC
CNNA
Cann American (CE)
USOTC
RDGL
Vivos (QB)
USOTC
ERHE
ERHC Energy (CE)
USOTC
KBLB
Kraig Biocraft Laborator... (QB)
USOTC
GTVH
Golden Triangle Ventures (PK)
USOTC
HIRU
Hiru (PK)
USOTC
AFFU
Affluence (PK)
USOTC
VDRM
ViaDerma (PK)
USOTC
SMCE
SMC Entertainment (PK)
USOTC
NWBO
Northwest Biotherapeutics (QB)
USOTC
GRST
Ethema Health (PK)
USOTC
FSRN
Fisker (PK)
Delayed Upgrade Clock
ADVFN Logo
InvestorsHub

Canada
Company
Business
Popular
Get The App
App Store
Google Play

Support: +44 (0) 203 8794 460 | support@advfn.com

By accessing the services available at ADVFN you are agreeing to be bound by ADVFN's Terms & Conditions

© 2024 ADVFN PLC - All Rights Reserved